Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Is Associated with Hyperinsulinemia and Insulin Resistance
Authors:
- Shirley LouieSLShirley Louie
- Philip A. KernPKPhilip A. Kern
- Vivian A. FonsecaVFVivian A. Fonseca
Open Access
- 1 August 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 56 (2) , 431-436
Abstract
High exposures of Vietnam veterans to 2,3,7,8-Tetrachlorodibenzo-p-dioxin, a dioxin contained in the herbicide mixture Agent Orange, have previously been demonstrated to be associated with an increased prevalence of diabetes and hyperinsulinemia in non-diabetic subjects. Sixty-nine persons were identified who were in good health and had normal glucose levels during glucose tolerance testing. These subjects lived within 25 miles of the Vertac/Hercules Superfund site located in Jacksonville, Arkansas. The blood sera lipid concentrations of TCDD for the 69 subjects ranged between 2 and 94 ppt. When subjects with blood sera lipid TCDD levels in the top 10% (TCDD > 15 ppt, n = 7) were compared to subjects with lower levels (2–15 ppt, n = 62), there were no group differences in age, obesity, gender distribution, total lipids, or glucose levels. However, plasma insulin concentrations, at fasting and 30, 60, and 120 min following a 75 g glucose load, were significantly higher in the group with high blood TCDD levels. These finding could not be explained by other known risk factors for hyperinsulinemia. The finding of the TCDD-hyperinsulinemia relationship is consistent with studies of Vietnam veterans and suggests that high blood TCDD levels may cause insulin resistance.Keywords
This publication has 25 references indexed in Scilit:
- Protection from obesity-induced insulin resistance in mice lacking TNF-α functionNature, 1997
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates function of human luteinizing granulosa cells via cAMP signaling and early reduction of glucose transporting activityReproductive Toxicology, 1996
- Effects of tumour necrosis factor alpha (TNFα) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell cultureDiabetologia, 1995
- Effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7Archives of Toxicology, 1995
- Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose- type" and "brain-type" glucose transporters in mice.Molecular Pharmacology, 1995
- The Relevance of Fat Content in Toxicity of Lipophilic Chemicals to Terrestrial Animals with Special Reference to Dieldrin and 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)Ecotoxicology and Environmental Safety, 1993
- Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasoneToxicology and Applied Pharmacology, 1992
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig.Journal of Biological Chemistry, 1992
- Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha.Journal of Biological Chemistry, 1991
- The Development and Prognosis of Chronic Intoxication by Tetrachlordibenzo-p-dioxin in MenArchives of Environmental Health: An International Journal, 1981